Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

BEXIMCO PHARMACEUTICALS LIMITED Half Year Results 2022-23

January 30, 2023 Business Services

Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic …
News
Press release

Kelso Pharma announces first product launch

January 30, 2023 Business Services

30th January 2023: Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the …
News
Press release

Pharmacists say England is not yet unlocking potential of self-care, with 77% backing the idea of a National Self-Care Strategy

January 30, 2023 Business Services

London, 30 January 2023. Today, a new report by Sanofi, an innovative global healthcare company, calls on the Government to …
News
Press release

Chiesi Farmaceutici hires new CEO after $1.48bn Amryst acquisition

January 30, 2023 Business Services

Chiesi Farmaceutici, a family-owned Italian pharmaceutical company, has appointed Giuseppe Accogli as group CEO. This comes after 2020’s $1.48bn acquisition …
News

Merck’s London research hub to begin construction in April 2023

January 26, 2023 Business Services

Merck has been planning a $1.3bn, 220,000 square foot research hub in London for six years but will finally begin …
News

t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells

January 26, 2023 Business Services

26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it …
News
Press release

Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease

January 26, 2023 Business Services

26 January 2023 Galway, Ireland – Orbsen Therapeutics Limited (“Orbsen”), a global leader in stromal cell immunotherapies, today announces encouraging …
News
Press release

First CAR T-cell therapy recommended for routine use on the NHS in England

January 26, 2023 Business Services

26th JANUARY 2023, LONDON, UK – Gilead Sciences Ltd. and Kite, a Gilead company, today announced that the National Institute …
News
Press release

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases

January 26, 2023 Business Services

Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …
News
Press release

Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition

January 26, 2023 Business Services

MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK …
News
Press release

US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections

January 25, 2023 Business Services

Brighton, United Kingdom – 25 January 2023 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on …
News
Press release

Vertex and CRISPR Therapeutics Announce EMA Marketing Authorization Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa

January 25, 2023 Business Services

LONDON, UK and ZUG, Switzerland, January 25, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that …
News
Press release

STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference

January 25, 2023 Business Services

25 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …
News
Press release

Scancell Holdings plc: Interim Results for the 6 months ended 31 October 2022

January 25, 2023 Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces …
News
Press release

Sosei Heptares Webinar Presentation for FY2022 Financial Results

January 25, 2023 Business Services

Tokyo, Japan and Cambridge, UK, 25 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025